Fiche centre
CHRU De Nancy
Nancy — France
Essais liés5clinical trials
VilleNancylocalisation
PaysFrancelocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07323316
Essais cliniques associés
5| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| NX210c | Sclérose latérale amyotrophique | Phase 2 | NCT06365216 | SEALS — ALS Phase II Study of NX210c | COMPLETED |
| MyoSense 360 | Myasthénie | Non applicable | NCT07323316 | HARMONY 360 — Holistic Assessment and Remote Digital MONitoring of mYasthenia Gravis Via MyoSense 360 | RECRUITING |
| Efgartigimod | Myasthénie | Phase 4 | NCT07072988 | OPTIMAGE — Evaluate the Benefit of Corticoid Sparing in Elderly With Generalized AntiRAch Myasthenia Gravis Treated With IV or SC Efgartigimod | RECRUITING |
| DIXI Medical Microdeep® Micro- Macro Depth electrodes | Épilepsie | Non applicable | NCT06105645 | NENUFAR — Contribution of Fast-ripples to the Improvement of the Neurosurgical Management of Drug-refractory Epilepsy | RECRUITING |
| PLASM-ALZ — Diagnostic Performance of Plasma Biomarkers of Alzheimer's Disease Compared With CSF Markers | Alzheimer | NA | NCT06304129 | PLASM-ALZ — Diagnostic Performance of Plasma Biomarkers of Alzheimer's Disease Compared With CSF Markers | NOT_YET_RECRUITING |